A Medical Device Daily

Bristol-Myers Squibb Medical Imaging (N. Billerica, Massachusetts) has adopted a new name, Lantheus Medical Imaging, and a new management team. The company says that this builds on momentum created by the recent acquisition of the business by Avista Capital Partners.

Don Kiepert was named president/CEO of Lantheus. Previously, Kiepert was the founder, former president/CEO and chairman of Point Therapeutics.

Lantheus has also reported adding key members of its management team: Phillip Lockwood, VP of HR, formerly VP of HR at Indevus Pharmaceuticals; and Michael Duffy, VP and general counsel, formerly senior VP/general counsel at Point Therapeutics. In addition, David Mann, formerly VP of sales, was promoted to VP of sales and marketing.

Additional members of the management team include Peter Card, VP of strategy and business development; William Dawes, VP of manufacturing and supply chain; Scott Edwards, VP of global R&D; Robert Gaffey, VP of finance and operations; and Cyrille Villeneuve, GM Canada, Latin America, Pacific Rim.

Lantheus develops imaging products that illuminate the heart and other organs.